POLAR NanoPharma

Nanomedical Solutions for Oncology

An Innovative Nanotechnology Platform for Oncology Applications

At Polar NanoPharma, we are committed to advancing cancer treatment through Ecostratar Technology, a revolutionary platform for creating robust and multifunctional nanocapsules using a one-pot process in aqueous system. This versatile nanotechnology platform enables precise, targeted drug delivery directly to tumor sites while ensuring intracellular release within cancer cells for enhanced therapeutic impact.

Our innovative and intelligent nanovehicle is designed to improve treatment efficacy while minimizing the side effects commonly associated with chemotherapy. By focusing on providing safer, more effective solutions for cancer therapies, Polar NanoPharma is dedicated to transforming oncology care and improving patient outcomes.







Clean & Scalable
Production Process

Efficient Water-Based and
One-Pot Synthetic Method. Free of Intermediate Steps and External Surfactants

Drug Stabilization
& Protection

Prevent Early Drug Degradation
and Leakage During Drug Circulation

Biocompatible & biodegradable

Safe Polymers that Enhance Drug Biodistribution and Reduce Systemic Drug-Related Toxicity and Side Effects


Versatile Platform

Designed Nanoparticles are Capable of Encapsulating a Broad Range of Molecules with Diverse Physicochemical Properties and without need of chemical modification. Including Small Molecules, Metal Complexes, Peptides or Proteins. Gene Therapies Under Investigation

TARGETED ACCUMULATION

Engineered Smart Nanoparticles Enhance Accumulation and Internalization in Response to local pH Changes, Creating an Ideal System for Targeting Tumor Lesions

STIMULATED RELEASE

Rationally Designed Polymers in Nanoparticle Shells Enable Targeted Drug Delivery with Biodegradable Groups for Controlled Release in Cancerous Cells


pipeline



Team


Ivan Ramos

Oriol Torres


Advisory board